A variety of truncated constructs of type I and type II adenylyl cycla
se have been synthesized in Sf9 cells using recombinant baculoviruses,
as have a number of type I adenylyl cyclases with point mutations. Tr
uncations indicate that the nonconserved C-1b and C-2b domains of aden
ylyl cyclase are not necessary for regulation of enzymatic activity by
G(s alpha) and forskolin. Point mutations demonstrate the requirement
for both of the conserved (and homologous) domains of adenylyl cyclas
e (C-1a and C-2a) and the nonequivalence of these domains. Linkage of
certain effects of mutations on the K-m for substrate with alterations
of the characteristics of beta-site inhibition suggest that ATP and b
eta-site inhibitors may bind to different conformations of the same si
te. However, other mutations affected only alpha-site inhibition. Alth
ough the mutations studied have not permitted assignment of unique fun
ctions to the two homologous domains, they have revealed novel phenoty
pes that appear to reflect the regulatory complexity of mammalian memb
rane-bound adenylyl cyclases, including the possibility of oligomeriza
tion of the enzymes.